TRUMBULL, Conn., Sept. 20, 2016 -- ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams.
Introduced to the healthcare market in 2014, sam® Sport is clinically proven to increase collagen laydown (accelerates the natural healing process in soft tissue), brings oxygenated blood to muscle tissues, accelerates angiogenesis (stimulates capillary development) and increases blood flow, which is important for muscle recovery, healing and healthy tissues.
sam® Sport (www.samsport.com) – manufactured in the United States and available by prescription from licensed healthcare professionals – is revolutionizing the treatment of soft-tissue injuries by significantly accelerating healing times, eliminating surgical procedures and reducing pain medication use.
Rick Guter, the head athletic trainer for USA Women’s Soccer, uses sam® Sport to treat both acute and chronic injuries. “For our soccer players we have a number of chronic groin muscle problems that have developed over time and this is one of the first devices that the athletes actually ask for,” he said.
Wally Blasé, former head athletic trainer for the NBA’s Atlanta Hawks and Chief Executive Officer of performance LLC works to rehabilitate professional athletes across the United States. “The key advantages of sam® Sport is the delivery of long-term ultrasound or sustained acoustic medicine, and to use it for deep-heat warming-up, recovery and treating injuries,” said Blasé. “The sam® Sport is nice, as you can put it on an athlete, set the timer and send them on their way.”
Beyond professional athletic programs, the medical device is growing in use among the general population and is covered by most worker’s compensation insurance carriers.
sam® Sport offers a non-invasive and non-addictive solution to eliminate America’s addiction to opioids and prescription drug abuse. George Lewis, Ph.D., Chief Executive Officer for ZetrOZ Systems, said: “The device is pre-approved by insurance for professional and collegiate athletes, and we have partnered with the largest insurance carriers to treat the workforce of America and get them off pain medication,” he explained. “The device allows the patient to obtain treatment while at work or on-the-go.”
sam® Sport is commonly prescribed for the non-invasive treatment of:
- Chronic tendinitis: elbow, bicep, tricep, shoulder;
- Shoulder/rotator cuff injuries and post-op recovery;
- Chronic back pain: lower back, sciatica and trapezius;
- Knee: meniscus tear and osteoarthritis (OA);
- Hamstring and groin strain and tears;
- Ankle injuries: sprain or frayed Achilles;
ZetrOZ Systems, LLC: ZetrOZ Systems, is a cGMP, ISO 13485 medical device manufacturer and sustained acoustic medicine pipeline development company. The company is the global leader in non-invasive medical devices to accelerate tissue healing and relieve pain for chronic musculoskeletal conditions.
For information, contact: Jim Molinaro Jr., chief commercial officer, ZetrOZ Systems LLC. [email protected] 888-507-8554


Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 



